Human Organoids for Predictive Toxicology Research and Drug Development
Overview
Authors
Affiliations
Organoids are three-dimensional structures fabricated in vitro from pluripotent stem cells or adult tissue stem cells a process of self-organization that results in the formation of organ-specific cell types. Human organoids are expected to mimic complex microenvironments and many of the physiological functions of relevant tissues, thus filling the translational gap between animals and humans and increasing our understanding of the mechanisms underlying disease and developmental processes. In the last decade, organoid research has attracted increasing attention in areas such as disease modeling, drug development, regenerative medicine, toxicology research, and personalized medicine. In particular, in the field of toxicology, where there are various traditional models, human organoids are expected to blaze a new path in future research by overcoming the current limitations, such as those related to differences in drug responses among species. Here, we discuss the potential usefulness, limitations, and future prospects of human liver, heart, kidney, gut, and brain organoids from the viewpoints of predictive toxicology research and drug development, providing cutting edge information on their fabrication methods and functional characteristics.
Current Treatment Regimens and Promising Molecular Therapies for Chronic Hepatobiliary Diseases.
Durazzo M, Ferro A, Navarro-Tableros V, Gaido A, Fornengo P, Altruda F Biomolecules. 2025; 15(1).
PMID: 39858515 PMC: 11763965. DOI: 10.3390/biom15010121.
Model Organoids: Integrated Frameworks for the Next Frontier of Healthcare Advancements.
Bhattacharya R, Bose D, Kaur T, Patel R, Renuka O, Rodriguez R Stem Cell Rev Rep. 2024; 21(2):319-336.
PMID: 39527389 DOI: 10.1007/s12015-024-10814-3.
Organoid intelligence for developmental neurotoxicity testing.
Alam El Din D, Shin J, Lysinger A, Roos M, Johnson E, Shafer T Front Cell Neurosci. 2024; 18:1480845.
PMID: 39440004 PMC: 11493634. DOI: 10.3389/fncel.2024.1480845.
Benboubker V, Ramzy G, Jacobs S, Nowak-Sliwinska P J Exp Clin Cancer Res. 2024; 43(1):259.
PMID: 39261955 PMC: 11389238. DOI: 10.1186/s13046-024-03173-x.
Asif K, Rahman M, Sfriso A, Parisi S, Canzonieri V, Caligiuri I RSC Adv. 2024; 14(36):26568-26579.
PMID: 39175687 PMC: 11339772. DOI: 10.1039/d4ra04433a.